Long-term Outcomes of Half-dose Photodynamic Therapy in Chronic Central Serous Chorioretinopathy

被引：0
|
作者：
Cheng, Zhihang [1 ]
Babiker, Salma [1 ]
Lenfestey, Pauline [1 ]
Beare, Nick [1 ]
Pearce, Ian A. [1 ]
机构：
[1] Royal Liverpool Univ Hosp, St Pauls Eye Unit, Liverpool, Merseyside, England
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2019年 / 60卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
5002
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Comparison of visual and anatomical outcomes of half-fluence and half-dose photodynamic therapy in eyes with chronic central serous chorioretinopathy
    Yong-Kyu Kim
    Na-Kyung Ryoo
    Se Joon Woo
    Kyu Hyung Park
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2015, 253 : 2063 - 2073
  • [32] Long-term results of half-fluence photodynamic therapy for chronic central serous chorioretinopathy
    Rouvas, Alexandros
    Stavrakas, Panagiotis
    Theodossiadis, Panagiotis G.
    Stamatiou, Polyxeni
    Milia, Maria
    Giannakaki, Emmanuela
    Datseris, Ioannis
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2012, 22 (03) : 417 - 422
  • [33] Comparative efficacy of brolucizumab, half-dose photodynamic therapy, and aflibercept in managing chronic central serous chorioretinopathy
    Yu-Te Huang
    Peng-Tai Tien
    Po-Yu Chen
    Chi-Lan Yang
    San-Ni Chen
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2024, 262 : 1755 - 1763
  • [34] Choroidal neovascularization secondary to half-dose photodynamic therapy for chronic central serous chorioretinopathy A case report
    Zhang, Zhengwei
    Bao, Xiaona
    Wu, Zhifeng
    Zhang, Jie
    MEDICINE, 2021, 100 (07) : E24790
  • [35] Comparative efficacy of brolucizumab, half-dose photodynamic therapy, and aflibercept in managing chronic central serous chorioretinopathy
    Huang, Yu-Te
    Tien, Peng-Tai
    Chen, Po-Yu
    Yang, Chi-Lan
    Chen, San-Ni
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2024, 262 (06) : 1755 - 1763
  • [36] Changes in Choroidal Structures in Eyes with Chronic Central Serous Chorioretinopathy after Half-Dose Photodynamic Therapy
    Kinoshita, Takamasa
    Mitamura, Yoshinori
    Mori, Terumi
    Akaiwa, Kei
    Semba, Kentaro
    Egawa, Mariko
    Mori, Junya
    Sonoda, Shozo
    Sakamoto, Taiji
    PLOS ONE, 2016, 11 (09):
  • [37] Safety and efficacy of fovea-involving half-dose photodynamic therapy for chronic central serous chorioretinopathy
    Feenstra, Helena Margaret Anthonia
    Diederen, Roselie M. H.
    Lamme, Martine J. C. M.
    Fauser, Sascha
    Downes, Susan M.
    Schlingemann, Reinier O.
    Hoyng, Carel C. B.
    van Dijk, Elon H. C.
    Boon, Camiel J. F.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2022, 63 (07)
  • [38] Outcome of half-dose photodynamic therapy in chronic central serous chorioretinopathy with fovea-involving atrophy
    van Rijssen, Thomas J.
    van Dijk, Elon H. C.
    Scholz, Paula
    MacLaren, Robert E.
    Fauser, Sascha
    Downes, Susan M.
    Hoyng, Carel B.
    Boon, Camiel J. F.
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2021, 259 (04) : 905 - 910
  • [39] Comprehensive evaluation of intravitreal conbercept versus half-dose photodynamic therapy for chronic central serous chorioretinopathy
    Mao, Jian-Bo
    Zhang, Cai-Yun
    Liu, Chen-Yi
    Zhang, Yun
    Lin, Jing-Jing
    Xu, Zhao-Kai
    Chen, Yi-Qi
    Fan, Yuan-Yuan
    Zhao, Shi-Xin
    Shen, Li-Jun
    INTERNATIONAL JOURNAL OF OPHTHALMOLOGY, 2021, 14 (05) : 719 - 724
  • [40] Comprehensive evaluation of intravitreal conbercept versus half-dose photodynamic therapy for chronic central serous chorioretinopathy
    Jian-Bo Mao
    Cai-Yun Zhang
    Chen-Yi Liu
    Yun Zhang
    Jing-Jing Lin
    Zhao-Kai Xu
    Yi-Qi Chen
    Yuan-Yuan Fan
    Shi-Xin Zhao
    Li-Jun Shen
    International Journal of Ophthalmology, 2021, 14 (05) : 719 - 724
12345